相似文献
1
Taking advantage of the disruptive impact of cell-free fetal DNA screening for aneuploidy.利用游离胎儿DNA筛查非整倍体的突破性影响。
Australas J Ultrasound Med. 2016 Aug 23;19(3):87-90. doi: 10.1002/ajum.12022. eCollection 2016 Aug.
2
Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013).母胎医学会咨询系列第 57 号：中孕期单纯性软指标超声标记物用于染色体非整倍体的评估与管理：（取代咨询 10 号：单脐动脉，2010 年 10 月；咨询 16 号：中孕期超声诊断孤立性肠回声增强，2011 年 8 月；咨询 17 号：中孕期超声检查孤立性肾盂扩张的评估与管理，2011 年 12 月；咨询 25 号：孤立性胎儿脉络丛囊肿，2013 年 4 月；咨询 27 号：孤立性心内强回声灶，2013 年 8 月）。
Am J Obstet Gynecol. 2021 Oct;225(4):B2-B15. doi: 10.1016/j.ajog.2021.06.079. Epub 2021 Jun 23.
3
Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.第640号委员会意见：游离DNA筛查胎儿非整倍体。
Obstet Gynecol. 2015 Sep;126(3):e31-e37. doi: 10.1097/AOG.0000000000001051.
4
Committee Opinion Summary No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.委员会意见摘要第640号：游离DNA筛查胎儿非整倍体
Obstet Gynecol. 2015 Sep;126(3):691-692. doi: 10.1097/01.AOG.0000471171.86798.ac.
5
Cell-free DNA screening for fetal aneuploidy as a clinical service.作为一项临床服务的胎儿非整倍体游离DNA筛查。
Clin Biochem. 2015 Oct;48(15):932-41. doi: 10.1016/j.clinbiochem.2015.02.011. Epub 2015 Feb 27.
6
Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.我们是否已进行了最后一次羊膜穿刺术？唐氏综合征筛查中游离DNA检测的最新进展。
Pediatr Radiol. 2018 Apr;48(4):461-470. doi: 10.1007/s00247-017-3958-y. Epub 2018 Mar 17.
7
[What are the real purpose and scope of screening for aneuploidy?].非整倍体筛查的真正目的和范围是什么？
Gynecol Obstet Fertil Senol. 2018 Feb;46(2):124-129. doi: 10.1016/j.gofs.2017.12.011. Epub 2018 Feb 1.
8
Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.短 cfDNA 片段测序可提高无创产前检测中胎儿 DNA 比例。
Am J Obstet Gynecol. 2019 Oct;221(4):345.e1-345.e11. doi: 10.1016/j.ajog.2019.05.023. Epub 2019 May 21.
9
Non invasive prenatal diagnosis of fetal aneuploidy using cell free fetal DNA.使用游离胎儿DNA进行胎儿非整倍体的无创产前诊断。
Eur J Obstet Gynecol Reprod Biol. 2018 Jun;225:5-8. doi: 10.1016/j.ejogrb.2018.03.033. Epub 2018 Mar 20.
10
SMFM Statement: clarification of recommendations regarding cell-free DNA aneuploidy screening.母胎医学会声明：关于游离DNA非整倍体筛查建议的澄清
Am J Obstet Gynecol. 2015 Dec;213(6):753-4. doi: 10.1016/j.ajog.2015.09.077. Epub 2015 Oct 14.
本文引用的文献
1
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.孕11至13周时通过母体因素和生物标志物筛查子痫前期的竞争风险模型
Am J Obstet Gynecol. 2016 Jan;214(1):103.e1-103.e12. doi: 10.1016/j.ajog.2015.08.034. Epub 2015 Aug 19.
2
Early fetal echocardiography: Experience of a tertiary diagnostic service.早期胎儿超声心动图：三级诊断服务的经验
Aust N Z J Obstet Gynaecol. 2015 Dec;55(6):552-8. doi: 10.1111/ajo.12379. Epub 2015 Jul 30.
3
Detection of Spina Bifida by First Trimester Screening - Results of the Prospective Multicenter Berlin IT-Study.孕早期筛查检测脊柱裂——前瞻性多中心柏林信息技术研究结果
Ultraschall Med. 2017 Apr;38(2):151-157. doi: 10.1055/s-0034-1399483. Epub 2015 Apr 14.
4
Cell-free DNA analysis for noninvasive examination of trisomy.游离 DNA 分析用于非侵入性的三体检查。
N Engl J Med. 2015 Apr 23;372(17):1589-97. doi: 10.1056/NEJMoa1407349. Epub 2015 Apr 1.
5
Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening.早发型子痫前期的预测与预防：孕早期筛查后阿司匹林的影响
Ultrasound Obstet Gynecol. 2015 Oct;46(4):419-23. doi: 10.1002/uog.14819. Epub 2015 Aug 31.
6
A cost-effectiveness analysis comparing different strategies to implement noninvasive prenatal testing into a Down syndrome screening program.一项比较将无创产前检测纳入唐氏综合征筛查项目的不同策略的成本效益分析。
Aust N Z J Obstet Gynaecol. 2014 Oct;54(5):412-7. doi: 10.1111/ajo.12223. Epub 2014 Sep 8.
7
Uterine artery pulsatility index assessment at 11-13 weeks' gestation.孕11至13周时子宫动脉搏动指数评估
Fetal Diagn Ther. 2014;36(4):299-304. doi: 10.1159/000361021. Epub 2014 Aug 1.
8
Ultrasound assessment of cervical length at 18-21 weeks' gestation in an Australian obstetric population: comparison of transabdominal and transvaginal approaches.澳大利亚产科人群妊娠18 - 21周时宫颈长度的超声评估：经腹与经阴道途径的比较
Aust N Z J Obstet Gynaecol. 2014 Jun;54(3):250-5. doi: 10.1111/ajo.12204. Epub 2014 Apr 5.
9
Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening.应用无创性产前检测的潜在诊断后果：来自有早期筛查的国家的基于人群的研究。
Ultrasound Obstet Gynecol. 2014 Mar;43(3):265-71. doi: 10.1002/uog.13270. Epub 2014 Feb 25.
10
Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy.孕早期预测妊娠高血压疾病风险算法的临床评估
Aust N Z J Obstet Gynaecol. 2013 Dec;53(6):532-9. doi: 10.1111/ajo.12126. Epub 2013 Aug 6.
Zotero 插件